NTRS
52
3
MET
69
3
SYK
40
-2
REGN
66
-3
SE
22
4
AMG
63
3
BLK
55
-3
GWW
60
-2
LEN
59
3
WM
71
-5
BRK.B
36
2
HBAN
71
15
NVDA
59
3
SCHW
67
2
SRCL
48
-2
WYNN
28
5
DLTR
47
-4
PRGO
33
-6
ORCL
54
2
SJM
55
-3
NTRS
52
3
MET
69
3
SYK
40
-2
REGN
66
-3
SE
22
4
AMG
63
3
BLK
55
-3
GWW
60
-2
LEN
59
3
WM
71
-5
BRK.B
36
2
HBAN
71
15
NVDA
59
3
SCHW
67
2
SRCL
48
-2
WYNN
28
5
DLTR
47
-4
PRGO
33
-6
ORCL
54
2
SJM
55
-3
Financhill
Back

Harmony Biosciences Holdings 10K Form

Buy
61

HRMY
Harmony Biosciences Holdings

Last Price:
31.02
Seasonality Move:
-13.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRMY News And Ratings

See the #1 stock for the next 7 days that we like better than HRMY

HRMY Financial Statistics

Sales & Book Value

Annual Sales: $437.86M
Cash Flow: $63.1M
Price / Cash Flow: 11.19
Annual Sales: $8.22
Price / Book: 3.77

Profitability

EPS (TTM): 2.46000
Net Income (TTM): $150.76M
Gross Margin: $354.37M
Return on Equity: 34.96%
Return on Assets: 21.11%

Harmony Biosciences Holdings Earnings Forecast

Key Harmony Biosciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 5 years for HRMY is 80.93%.
  • The Selling, General & Administrative Expenses for HRMY have been equal to 37.30% of Gross Profit Margin.
  • The Research & Development expenses have been 16.19% of Revenue.
  • The Interest Expense is 8.64% of Operating Income.
  • The Net Earning history of HRMY is 41.44% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

Harmony Biosciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: HRMY
Website: harmonybiosciences.com

Debt

Debt-to-Equity Ratio: 0.41
Current Ratio: 4.12
Quick Ratio: 3.9

Price-to-Earnings

Trailing P/E Ratio: 10.44
Forward P/E Ratio: 7.25

HRMY Technical Analysis vs Fundamental Analysis

Buy
61
Harmony Biosciences Holdings (HRMY) is a Buy

Is Harmony Biosciences Holdings a Buy or a Sell?